Recent Updates
Recently added Catalysts
JNJ Positive Sentiment

Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%

Tuesday, April 14, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Johnson & Johnson has announced a 3.1% increase in its quarterly dividend, marking the 64th consecutive year of dividend growth. This decision reflects the company's ongoing commitment to returning value to its shareholders and showcases its financial stability. The increase is a positive indicator of the company's performance and future outlook.
Price reaction · baseline $237.96 (2026-04-13 close) · hit after-hours · 2 other JNJ headline(s) in the window, move may be shared
day 0 close
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • 64th consecutive year of dividend increase
  • Quarterly dividend raised by 3.1%
  • Demonstrates financial stability and commitment to shareholders

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 3.1% increase in the quarterly dividend, from $1.30 per share to $1.34 per share, marking the 64thyear of consecutive increases.
At the new rate, the indicated dividend on an annual basis is $5.36 per share compared to the previous rate of $5.20 per share. The next quarterly dividend is payable on June 9, 2026 to shareholders of record at the close of business on May 26, 2026. The ex-dividend date is May 26, 2026.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more athttps://www.jnj.com/.

Frequently Asked Questions

What is the percentage increase in JNJ's dividend?

Johnson & Johnson raised its quarterly dividend by 3.1%.

How many consecutive years has JNJ increased its dividend?

JNJ has increased its dividend for 64 consecutive years.

What does the dividend increase indicate?

The increase reflects JNJ's financial stability and commitment to shareholders.

ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare dividend increase quarterly dividend financial stability shareholder value
Last updated: Apr 14, 2026

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
CanagliflozinPhase 3
Diabetes Mellitus, Type 2 →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →